Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$829,429
-$56,494 QoQ
Shares Held
35,205
+15.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invst, LLC holds $1,765,143 across 8 Biotechnology names. ARQT ranks #1 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
35,205 | $829,429 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,998 | $337,701 | |
| 3 | INCY |
Incyte Corp
|
3,447 | $324,431 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
16,000 | $84,640 | |
| 5 | HURA |
TuHURA Biosciences, Inc./NV
|
42,506 | $76,085 | |
| 6 | CRDF |
Cardiff Oncology, Inc.
|
40,500 | $65,610 | |
| 7 | MRKR |
Marker Therapeutics, Inc.
|
29,000 | $37,700 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
23,400 | $9,547 |
All Filings in ARQT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $829,429 | 35,205 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $885,923 | 30,507 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $605,216 | 32,107 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $421,679 | 30,077 | Shares | Sole | 2025-10-16 | |
| 2025-03-31 | $322,997 | 20,652 | Shares | Sole | 2025-06-03 | |
| No filing history on record for this holder in this stock. | ||||||